✦ LIBER ✦

Good tolerance of weekly oral idarubicin: (4-demethoxydaunorubicin): A phase I study with pharmacology

✍ Scribed by Howard Hochster; Michael Green; Leonard Liebes; James L. Speyer; James Wernz; Ronald Blum; Franco Muggia

Publisher: Springer
Year: 1990
Tongue: English
Weight: 438 KB
Volume: 26
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf02897234

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial of 4-demethoxydaunorubicin

Phase I trial of 4-demethoxydaunorubicin (idarubicin) with single oral doses

✍ S. Kaplan; C. Sessa; Y. Willems; M. A. Pacciarini; V. Tamassia; F. Cavalli 📂 Article 📅 1984 🏛 Springer US 🌐 English ⚖ 454 KB

Twenty-four patients with a variety of solid tumors entered a Phase I trial with 4-demethoxydaunorubicin, a new analogue of daunorubicin. The drug was given as a single oral dose of 10-60 mg/m 2 repeated every 3-4 weeks. Leukopenia was the dose-limiting toxicity. Other toxic effects included mild t

A phase II study of oral idarubicin (4-d

A phase II study of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer

✍ Nicholas S. A. Stuart; Michael H. Cullen; Terrence J. Priestman; George R. P. Bl 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 352 KB

Idarubicin (4-demethoxydaunorubicin: DMDNR) is an orally active analogue of daunorubicin that has shown promising activity in animal and early clinical studies. We gave idarubicin in a phase II study to patients with advanced breast cancer unresponsive to hormonal manipulation and in some cases to s

Treatment of myelodysplastic syndromes w

Treatment of myelodysplastic syndromes with daily oral idarubicin. A phase I–II study

✍ Bernard R. Greenberg; Ralph D. Reynolds; Carolyn B. Charron; Kathleen M. Squilla 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB 👁 2 views

A phase I and pharmacologic study of wee

A phase I and pharmacologic study of weekly gemcitabine in combination with infusional 5-fluorodeoxyuridine and oral calcium leucovorin

✍ JeanL. Grem; MaryG. Quinn; Bruce Keith; BrianP. Monahan; J.Michael Hamilton; Yan 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 275 KB

A phase I/II study of oral etoposide and

A phase I/II study of oral etoposide and idarubicin in elderly patients with high-risk acute myeloid leukemia unable to undergo intensive chemotherapy

✍ Michael Fiegl; Thomas Büchner; Wolfgang Hiddemann; Jan Braess 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 84 KB

A Phase I/II study of weekly paclitaxel

A Phase I/II study of weekly paclitaxel and 3 days of high dose oral estramustine in patients with hormone-refractory prostate carcinoma

✍ Anna C. Ferrari; Abraham Chachoua; Harvinder Singh; Mark Rosenthal; Samir Taneja 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views